{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:12:15Z","timestamp":1788840735074,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019217","name":"AlMaarefa University","doi-asserted-by":"publisher","award":["MHIRSP2025007"],"award-info":[{"award-number":["MHIRSP2025007"]}],"id":[{"id":"10.13039\/100019217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014786","name":"Northern Border University","doi-asserted-by":"publisher","award":["NBU-FPEJ-2026-3105-03"],"award-info":[{"award-number":["NBU-FPEJ-2026-3105-03"]}],"id":[{"id":"10.13039\/501100014786","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.coph.2026.102660","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:37:51Z","timestamp":1786405071000},"page":"102660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The vasopressin system as an immunoneuroendocrine therapeutic target in inflammatory conditions"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1778-1631","authenticated-orcid":false,"given":"Hany A.","family":"Elkattawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar K.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eslam Kamal","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesam M.R.","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2026.102660_bib1","series-title":"Hydro saline metabolism. Endocrinology","article-title":"Syndrome of inappropriate antidiuresis","author":"Ferrante","year":"2023"},{"key":"10.1016\/j.coph.2026.102660_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fmed.2015.00019","article-title":"A review of the nonpressor and nonantidiuretic actions of the hormone vasopressin","volume":"2","author":"Mavani","year":"2015","journal-title":"Front Med"},{"key":"10.1016\/j.coph.2026.102660_bib3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.37349\/emed.2022.00103","article-title":"Vasopressin: a possible link between hypoxia and hypertension","volume":"3","author":"Szczepa\u0144ska-Sadowska","year":"2022","journal-title":"Explor Med"},{"key":"10.1016\/j.coph.2026.102660_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2003.11.049","article-title":"Multiple effects of arginine vasopressin on prostaglandin E2 synthesis in fibroblasts","volume":"485","author":"Fleisher-Berkovich","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2026.102660_bib5","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1038\/s41598-024-55772-5","article-title":"The possible role of the vasopressin system in hematopoiesis","volume":"14","author":"Schill","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2026.102660_bib6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1749-6632.2000.tb05448.x","article-title":"Perturbations of arginine vasopressin secretion during inflammatory stress. Pathophysiologic implications","volume":"917","author":"Chikanza","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.coph.2026.102660_sref7","series-title":"Vasopressin and oxytocin receptors in GtoPdb v.2025.3","author":"Bichet","year":"2025"},{"key":"10.1016\/j.coph.2026.102660_sref8","article-title":"Inflammation and vasopressin hypersecretion in aging","volume":"16","author":"Mutig","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.coph.2026.102660_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/bs.mie.2024.04.016","article-title":"Design and synthesis of oxytocin glycosides for the treatment of pain and substance use disorder","volume":"698","author":"Goodman","year":"2024","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.coph.2026.102660_sref10","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/s41467-026-68331-5","article-title":"Molecular basis of antagonism of the dimeric human arginine vasopressin receptor 1A","volume":"17","author":"Zhong","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2026.102660_bib11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1210\/me.2006-0202","article-title":"Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors","volume":"21","author":"Rodrigo","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.coph.2026.102660_sref12","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1038\/s41467-025-59114-5","article-title":"Inactive structures of the vasopressin V2 receptor reveal distinct binding modes for tolvaptan and mambaquaretin toxin","volume":"16","author":"Fouillen","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2026.102660_sref13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1021\/acsmedchemlett.6c00105","article-title":"SAR-guided scaffold innovation of selective V2R antagonists: therapeutic frontiers in ADPKD","volume":"17","author":"Shi","year":"2026","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.coph.2026.102660_sref14","doi-asserted-by":"crossref","DOI":"10.1002\/bip.23627","article-title":"Structural basis for antagonist binding to vasopressin V1b receptor revealed by molecular dynamics simulations","volume":"116","author":"\u015alusarz","year":"2025","journal-title":"Biopolymers"},{"key":"10.1016\/j.coph.2026.102660_bib15","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1152\/physrev.00035.2011","article-title":"Vasopressin V1a and V1b receptors: from molecules to physiological systems","volume":"92","author":"Koshimizu","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.coph.2026.102660_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuropharm.2018.11.010","article-title":"Arrestin recruitment and signaling by G protein-coupled receptor heteromers","volume":"152","author":"Mores","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.coph.2026.102660_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg5628","article-title":"Cryo-electron microscopy structure of the antidiuretic hormone arginine-vasopressin V2 receptor signaling complex","volume":"7","author":"Bous","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.coph.2026.102660_bib18","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1111\/febs.15749","article-title":"Noncanonical interactions of G proteins and \u03b2-arrestins: from competitors to companions","volume":"288","author":"Smith","year":"2021","journal-title":"FEBS J"},{"key":"10.1016\/j.coph.2026.102660_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1124\/molpharm.122.000497","article-title":"Michaelis-Menten quantification of ligand signaling bias applied to the promiscuous vasopressin V2 receptor","volume":"102","author":"Heydenreich","year":"2022","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2026.102660_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yfrne.2017.10.004","article-title":"Cross-talk among oxytocin and arginine-vasopressin receptors: relevance for basic and clinical studies of the brain and periphery","volume":"51","author":"Song","year":"2018","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.coph.2026.102660_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.564485","article-title":"Involvement of oxytocin receptor\/Erk\/MAPK signaling in the mPFC in early life stress-induced autistic-like behaviors","volume":"8","author":"Wei","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.coph.2026.102660_bib22","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1111\/bph.15481","article-title":"Oxytocin and vasopressin: signalling, behavioural modulation and potential therapeutic effects","volume":"179","author":"Rae","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2026.102660_bib23","doi-asserted-by":"crossref","first-page":"F43","DOI":"10.1152\/ajprenal.00229.2022","article-title":"Data resource: vasopressin-regulated protein phosphorylation sites in the collecting duct","volume":"324","author":"Park","year":"2023","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.coph.2026.102660_bib24","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.3390\/ijms25137394","article-title":"The interaction of vasopressin with hormones of the hypothalamo-pituitary-adrenal axis: the significance for therapeutic strategies in cardiovascular and metabolic diseases","volume":"25","author":"Szczepanska-Sadowska","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102660_sref25","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3390\/ijms26062512","article-title":"Effect of arginine vasopressin on human neutrophil function under physiological and sepsis-associated conditions","volume":"26","author":"Haile","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102660_bib26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/j.2040-4603.2016.tb00694.x","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response","volume":"6","author":"Herman","year":"2016","journal-title":"Compr Physiol"},{"key":"10.1016\/j.coph.2026.102660_bib27","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.3390\/ijms26167812","article-title":"Vagal oxytocin receptors as molecular targets in gut-brain signaling: implications for appetite, satiety, obesity, and esophageal motility-a narrative review","volume":"26","author":"Nowacka","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102660_bib28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1113\/jphysiol.2007.129569","article-title":"Hyperammonaemia in V1a vasopressin receptor knockout mice caused by the promoted proteolysis and reduced intrahepatic blood volume","volume":"581","author":"Hiroyama","year":"2007","journal-title":"J Physiol"},{"key":"10.1016\/j.coph.2026.102660_bib29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/sj.mp.4001195","article-title":"Vasopressin V1b receptor knockout reduces aggressive behavior in male mice","volume":"7","author":"Wersinger","year":"2002","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.coph.2026.102660_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.physbeh.2009.02.006","article-title":"Persistence of reduced aggression in vasopressin 1b receptor knockout mice on a more \u201cwild\u201d background","volume":"97","author":"Caldwell","year":"2009","journal-title":"Physiol Behav"},{"key":"10.1016\/j.coph.2026.102660_bib31","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1172\/JCI9154","article-title":"Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene","volume":"106","author":"Yun","year":"2000","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coph.2026.102660_bib32","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.3390\/ijms23063068","article-title":"Vasopressin and its analogues: from natural hormones to multitasking peptides","volume":"23","author":"Glava\u0161","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102660_sref33","doi-asserted-by":"crossref","first-page":"9734","DOI":"10.1038\/s41467-025-64735-x","article-title":"Structural insights into antagonist recognition by the vasopressin V2 receptor","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2026.102660_bib34","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2147\/NDT.S402831","article-title":"Targeting the arginine vasopressin V1b receptor system and stress response in depression and other neuropsychiatric disorders","volume":"19","author":"Kanes","year":"2023","journal-title":"Neuropsychiatric Dis Treat"},{"key":"10.1016\/j.coph.2026.102660_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/bs.vh.2019.08.012","article-title":"V2 vasopressin receptor mutations","volume":"113","author":"Makita","year":"2020","journal-title":"Vitam Horm"},{"key":"10.1016\/j.coph.2026.102660_bib36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.mvr.2013.09.001","article-title":"Desmopressin improves intestinal functional capillary density and decreases leukocyte activation in experimental endotoxemia","volume":"97","author":"Wafa","year":"2015","journal-title":"Microvasc Res"},{"key":"10.1016\/j.coph.2026.102660_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105272","article-title":"Arginine vasopressin receptor 2 activation promotes microvascular permeability in sepsis","volume":"163","author":"Lopez","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.coph.2026.102660_bib38","doi-asserted-by":"crossref","first-page":"14853","DOI":"10.1021\/acs.jmedchem.3c01415","article-title":"Photoswitchable probes of oxytocin and vasopressin","volume":"66","author":"Wirth","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2026.102660_bib39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/SHK.0000000000002515","article-title":"The effect of catecholamine versus noncatecholamine vasopressors on renal function and recovery in vasodilatory shock: a systematic review of preclinical and clinical studies","volume":"63","author":"Vernon-Elliot","year":"2025","journal-title":"Shock"},{"key":"10.1016\/j.coph.2026.102660_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112193","article-title":"Arginine vasopressin and pathophysiology of COVID-19: an innovative perspective","volume":"143","author":"Al-Kuraishy","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.coph.2026.102660_bib41","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000445480","article-title":"Control of stress-induced ACTH secretion by vasopressin and CRH: additional evidence","volume":"73","author":"Ramos","year":"2016","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.coph.2026.102660_bib42","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/cen.12608","article-title":"Gender-specific co-activation of arginine vasopressin and the hypothalamic-pituitary-adrenal axis during stress","volume":"82","author":"Kacheva","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.coph.2026.102660_bib43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11102-015-0703-0","article-title":"Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system","volume":"19","author":"Rotondo","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.coph.2026.102660_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115265","article-title":"Melatonin alleviates arginine vasopressin-induced cardiomyocyte apoptosis via increasing Mst1-Nrf2 pathway activity to reduce oxidative stress","volume":"206","author":"Chen","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coph.2026.102660_bib45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2015.04.006","article-title":"Vasopressin attenuates ischemia-reperfusion injury via reduction of oxidative stress and inhibition of mitochondrial permeability transition pore opening in rat hearts","volume":"760","author":"Nazari","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2026.102660_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-8703(02)94708-3","article-title":"Vasopressin: a new target for the treatment of heart failure","volume":"146","author":"Lee","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.coph.2026.102660_bib47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jtha.2022.11.018","article-title":"Akt-mediated mitochondrial metabolism regulates proplatelet formation and platelet shedding post vasopressin exposure","volume":"21","author":"Chen","year":"2023","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.coph.2026.102660_bib48","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1007\/s12035-016-0094-x","article-title":"Vasopressin impairment during sepsis is associated with hypothalamic intrinsic apoptotic pathway and microglial activation","volume":"54","author":"da Costa","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.coph.2026.102660_sref49","article-title":"Comparison of short-term and long-term renal function effects of vasopressin and norepinephrine in patients with septic shock: a systematic review and meta-analysis","volume":"16","author":"Wang","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coph.2026.102660_bib50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12902-024-01664-8","article-title":"Arginine vasopressin deficiency onset after COVID-19 vaccination with positive anti-rabphilin-3A antibodies: a case report and literature review","volume":"24","author":"Takizawa","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.coph.2026.102660_sref51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12902-025-01992-3","article-title":"Hypothalamic-pituitary-adrenal dynamics in early-stage COVID-19 observed in a case with arginine vasopressin deficiency","volume":"25","author":"Kirikae","year":"2025","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.coph.2026.102660_bib52","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.7150\/ijms.46302","article-title":"Terlipressin relieves intestinal and renal injuries induced by acute mesenteric ischemia via PI3K\/Akt pathway","volume":"17","author":"Liu","year":"2020","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.coph.2026.102660_bib53","first-page":"409","article-title":"The protective effect of vasopressin on sperm parameters and histopathology of testicular and epididymal tissue in a rat model of testicular torsion-detorsion","volume":"53","author":"Fazilatpour","year":"2022","journal-title":"Egypt J Vet Sci"},{"key":"10.1016\/j.coph.2026.102660_sref54","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2026.103454","article-title":"Modulating the oxidative and inflammatory response: the therapeutic potential of vasopressin in ovarian torsion-detorsion injury","volume":"101","author":"Elkattawy","year":"2026","journal-title":"Tissue Cell"},{"key":"10.1016\/j.coph.2026.102660_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1138627","article-title":"Arginine vasopressin hormone receptor antagonists in experimental autoimmune encephalomyelitis rodent models: a new approach for human multiple sclerosis treatment","volume":"17","author":"Calvillo-Robledo","year":"2023","journal-title":"Front Neurosci"},{"key":"10.1016\/j.coph.2026.102660_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2024.104572","article-title":"Identification of arginine-vasopressin receptor 1a (Avpr1a\/Avpr1a) as a novel candidate gene for chronic visceral pain sheds light on the potential role of enteric neurons in the development of visceral hypersensitivity","volume":"25","author":"Kader","year":"2024","journal-title":"J Pain"},{"key":"10.1016\/j.coph.2026.102660_bib57","article-title":"Neurotransmitter and intestinal interactions: focus on the microbiota-gut-brain axis in irritable bowel syndrome","volume":"13","author":"Chen","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.coph.2026.102660_bib58","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/cc8224","article-title":"Bench-to-bedside review: vasopressin in the management of septic shock","volume":"15","author":"Russell","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.coph.2026.102660_bib59","doi-asserted-by":"crossref","first-page":"69276","DOI":"10.18632\/oncotarget.12472","article-title":"Signaling through hepatocyte vasopressin receptor 1 protects mouse liver from ischemia-reperfusion injury","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.coph.2026.102660_bib60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12964-024-01620-y","article-title":"Endothelial cell dynamics in sepsis-induced acute lung injury and acute respiratory distress syndrome: pathogenesis and therapeutic implications","volume":"22","author":"Qiao","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.coph.2026.102660_bib61","first-page":"151","article-title":"The anti-inflammatory effect of arginine-vasopressin on lipopolysaccharide-induced I\u03baB\u03b1\/nuclear factor-\u03baB cascade","volume":"30","author":"Park","year":"2015","journal-title":"Acute Crit Care"},{"key":"10.1016\/j.coph.2026.102660_bib62","doi-asserted-by":"crossref","first-page":"G1298","DOI":"10.1152\/ajpgi.00022.2010","article-title":"Proinflammatory role of vasopressin through V1b receptors in hapten-induced experimental colitis in rodents: implication in IBD","volume":"299","author":"Ferrier","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2026.102660_bib63","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/ijms24021325","article-title":"Involvement of vasopressin in tissue hypoperfusion during cardiogenic shock complicating acute myocardial infarction in rats","volume":"24","author":"Gaudard","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489226000561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489226000561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:02:59Z","timestamp":1788840179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489226000561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":63,"alternative-id":["S1471489226000561"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2026.102660","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The vasopressin system as an immunoneuroendocrine therapeutic target in inflammatory conditions","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2026.102660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102660"}}